Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-000124467 in relapsing-remitting multiple sclerosis assessed by MRI
2004-000073-64Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing L-000124467 with Placebo (2 arms). Primary endpoints: MRI-detected favorable changes in brain lesion number or extent compared with placebo, Reduction in development of brain lesions from baseline and 1 more. Started Jul 2004; status: completed.
02
Drugs
mk-0812
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-000073-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000073-64.